Drugs / Autologous, tumor lysate-loaded, mature dendritic cells
Autologous, tumor lysate-loaded, mature dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03395587 | Mar 2018 → May 2027 expected | glioblastoma | Heinrich-Heine University, Duesseldorf | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous, tumor lysate-loaded, mature dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03395587 ↗ |
| Modality | Cell therapy | “lysate-loaded, mature dendritic cell vaccines” NCT03395587 ↗ |
| Route | Other | “intradermal injection” NCT03395587 ↗ |